Who Paid My Doc
P3 AD Monotherapy Induction
Research payments
$737,081
Through program year 2023, $737,081 in research payments was reported against P3 AD Monotherapy Induction, across 74 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $737,081 | 74 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ali Moiin Troy, MI Named on 2 payments
- Kevin O'Brien Denver, CO Named on 2 payments
- Stacy Smith Encinitas, CA Named on 2 payments
- John Randall West Lafayette, IN Named on 2 payments
- Michael Heaphy Reno, NV Named on 2 payments
- Myron Zhang Spokane, WA Named on 2 payments
- Michael Waters Chula Vista, CA Named on 2 payments
- Manuel Sanchez Hialeah, FL Named on 2 payments
- Hollis Clark Murray, KY Named on 2 payments
- John Delgado Los Angeles, CA Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.